Short answer · Medically reviewed summary · Last updated: 2026-05-08
Henoch-Schönlein purpura (HSP), now clinically referred to as IgA vasculitis, has an estimated annual incidence of 10 to 20 per 100,000 children, making it the most common form of systemic vasculitis in childhood. While it is considered a rare disease in adults, the true prevalence remains difficult to quantify due to mild, self-limiting cases that may go undiagnosed or misreported in medical literature. What is the incidence and prevalence of Henoch-Schönlein purpura? The incidence of Henoch-Schönlein purpura varies significantly by age and region.
1 people with Henoch-Schönlein purpura have shared their first-person experience on this question at DiseaseMaps.
Henoch-Schönlein purpura (HSP), now clinically referred to as IgA vasculitis, has an estimated annual incidence of 10 to 20 per 100,000 children, making it the most common form of systemic vasculitis in childhood. While it is considered a rare disease in adults, the true prevalence remains difficult to quantify due to mild, self-limiting cases that may go undiagnosed or misreported in medical literature.
The incidence of Henoch-Schönlein purpura varies significantly by age and region. While pediatric cases are relatively frequent, adult-onset cases are far less common, often presenting with more severe renal involvement. Current epidemiological data suggests that Henoch-Schönlein purpura affects males slightly more frequently than females, with a ratio of approximately 1.5:1. Because many cases resolve spontaneously without hospitalization, these numbers likely underestimate the actual burden of the disease globally.
The peak age of onset for Henoch-Schönlein purpura is between 3 and 15 years, with the majority of cases occurring before age 10. However, the condition can occur at any age, including in adults. When Henoch-Schönlein purpura occurs in adults, it is frequently associated with a higher risk of long-term kidney complications compared to the pediatric population.
Research indicates that Henoch-Schönlein purpura shows seasonal variability, often peaking in the winter and spring, which correlates with the prevalence of upper respiratory infections. Regarding demographics, the following observations have been documented:
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.